41. Motellon JL, Jimenez FJ, de Miguel F, et al. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
Clin Chim Acta 2000;302:59-68.
42. Barthez PY, Davis CR, Pool RR, et al. Multiple metaphyseal involvement of a thymic lymphoma associated with hypercalcemia
in a puppy. J Am Anim Hosp Assoc 1995;31:82-85.
43. Villiers E, Dobson J. Multiple myeloma with associated polyneuropathy in a German shepherd dog. J Small Anim Pract 1998;39:249-251.
44. Matus RE, Leifer CE, MacEwen EG, et al. Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 1986;188:1288-1292.
45. Brater DC. Clinical pharmacology of loop diuretics. Drugs 1991;41(Suppl 3):14-22.
46. Puschett JB. Pharmacological classification and renal actions of diuretics. Cardiology 1994;84(Suppl 2):4-13.
47. Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus injection versus continuous infusion of furosemide in normal adult
greyhound dogs. J Vet Intern Med 2003;17:632-636.
48. Price GS, Page RL, Fischer BM, et al. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with
multicentric lymphosarcoma. J Vet Intern Med 1991;5:259-262.
49. Body JJ, Coleman RE, Piccart M. Use of bisphosphonates in cancer patients. Cancer Treat Rev 1996;22:265-287.
50. Tenta R, Sourla A, Lembessis P, et al. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor
bioregulation systems in MG-63 human osteosarcoma cells. Anticancer Res 2006;26(1A):283-291.
51. Milner RJ, Farese J, Henry CJ, et al. Bisphosphonates and cancer. J Vet Intern Med 2004;18:597-604.
52. Rogers MJ, Watts DJ, Russell RG. Overview of bisphosphonates. Cancer 1997;80(8 Suppl):1652-1660.
53. Sonnemann J, Eckervogt V, Truckenbrod B, et al. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma
cell growth in vitro. Anticancer Drugs 2001;12:459-465.
54. Rumbeiha WK, Fitzgerald SD, Kruger JM, et al. Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in
dogs. Am J Vet Res 2000;61:9-13.
55. Rumbeiha WK, Kruger JM, Fitzgerald SF, et al. Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs. Am J Vet Res 1999;60:1092-1097.
56. Hostutler RA, Chew DJ, Jaeger JQ, et al. Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with
hypercalcemia. J Vet Intern Med 2005;19:29-33.
57. Fan TM, de Lorimier LP, Charney SC, et al. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs
with primary or secondary bone involvement. J Vet Intern Med 2005;19:74-80.
58. Rosol T, Chew D, Hammer A. Effect of mithramycin on hypercalcemia in dogs. J Am Anim Hosp Assoc 1994;30:244-250.
|
Featuring Information from:
